This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| BTG | Jefferies ups TP to 420p from 400p, Hold |
| CRH | SocGen ups TP to 1270p from 1200p, sell |
| Dixons Retail | Citigroup ups TP to 60p, Buy |
| Etalon | JP Morgan initiates with overweight; TP $7 |
| Fenner | Liberum ups TP to 515p from 410p, Buy |
| Fenner | Finncap ups to Buy from Hold; ups TP to 460p |
| Halfords | HSBC ups TP to 530p from 380p, neutral |
| Hunting | Liberum cuts TP by 2 percent to 808p, Hold |
| Imagination Technologies | Goldman Sachs cuts TP to 350p from 400p, Buy |
| International Consolidated Airlines | Morgan Stanley ups TP to 5 euros from 4.90 euros, overweight |
| Interserve | Liberum ups TP to 650p from 600p, Buy |
| IQE | N+1 Singer cuts TP to 35p from 45p, Buy |
| John Menzies | JP Morgan downgrades to neutral from overweight; cuts TP to 807p from 884p |
| Lloyds | Liberum ups TP to 85p from 62p, Buy |
| LSR | JP Morgan ups to overweight from neutral; cuts TP to $5.15 from $5.50 |
| PZ Cussons | Goldman Sachs ups to Buy |
| Redrow | Liberum ups TP to 320p from 304p, Buy |
| Talktalk | Morgan Stanley ups TP to 300p from 280p, overweight |
| Tesco | HSBC downgrades to neutral from overweight; cuts TP to 400p from 430p |
| Wolseley | Morgan Stanley ups to overweight from Equalweight; ups TP to 3575p from 3050p |
| Xchanging | Liberum ups to Buy from Hold; ups TP to 160p from 145p |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research